Definitive Healthcare (DH) Set to Announce Earnings on Thursday

Definitive Healthcare (NASDAQ:DHGet Rating) will release its earnings data after the market closes on Thursday, May 5th. Analysts expect Definitive Healthcare to post earnings of $0.01 per share for the quarter. Definitive Healthcare has set its Q1 2022 guidance at $0.020-$0.040 EPS and its FY 2022 guidance at $0.220-$0.260 EPS.Persons interested in participating in the company’s earnings conference call can do so using this link.

Definitive Healthcare (NASDAQ:DHGet Rating) last released its quarterly earnings results on Wednesday, February 23rd. The company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.02. The firm had revenue of $46.31 million for the quarter, compared to the consensus estimate of $44.78 million. On average, analysts expect Definitive Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

DH opened at $23.05 on Thursday. The company has a debt-to-equity ratio of 0.18, a current ratio of 3.77 and a quick ratio of 3.77. The company’s 50-day moving average is $23.33 and its 200 day moving average is $27.70. Definitive Healthcare has a fifty-two week low of $18.15 and a fifty-two week high of $50.30.

In other news, CFO Richard Douglas Booth acquired 2,374 shares of Definitive Healthcare stock in a transaction that occurred on Thursday, March 3rd. The stock was bought at an average price of $21.06 per share, with a total value of $49,996.44. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Institutional investors have recently made changes to their positions in the business. BlackRock Inc. lifted its holdings in shares of Definitive Healthcare by 50.4% in the 4th quarter. BlackRock Inc. now owns 2,256,587 shares of the company’s stock worth $61,672,000 after acquiring an additional 756,587 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Definitive Healthcare by 265.3% in the 4th quarter. Geode Capital Management LLC now owns 333,018 shares of the company’s stock worth $9,101,000 after acquiring an additional 241,849 shares during the last quarter. State Street Corp bought a new stake in Definitive Healthcare during the 4th quarter valued at $4,153,000. Charles Schwab Investment Management Inc. bought a new stake in Definitive Healthcare during the 4th quarter valued at $3,622,000. Finally, Wells Fargo & Company MN raised its holdings in Definitive Healthcare by 1,110.4% during the 4th quarter. Wells Fargo & Company MN now owns 55,932 shares of the company’s stock valued at $1,529,000 after buying an additional 51,311 shares during the last quarter. Institutional investors and hedge funds own 97.34% of the company’s stock.

A number of research firms recently weighed in on DH. Deutsche Bank Aktiengesellschaft raised their price target on shares of Definitive Healthcare from $21.00 to $26.00 and gave the company a “hold” rating in a research report on Tuesday, April 5th. Canaccord Genuity Group upgraded shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, February 24th. Zacks Investment Research downgraded shares of Definitive Healthcare from a “hold” rating to a “sell” rating in a report on Monday, April 18th. Barclays decreased their price objective on shares of Definitive Healthcare from $26.00 to $23.00 in a report on Thursday, February 24th. Finally, Canaccord Genuity Group upgraded shares of Definitive Healthcare from a “hold” rating to a “buy” rating and decreased their price objective for the stock from $46.00 to $28.00 in a report on Thursday, February 24th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $37.00.

Definitive Healthcare Company Profile (Get Rating)

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution.

See Also

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.